| Paul David Cochran, | |
|
1055 N Curtis Rd, Boise, ID 83706-1309 | |
| (208) 367-2559 | |
| Not Available |
| Full Name | Paul David Cochran |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 5 Years |
| Location | 1055 N Curtis Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104477967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 62753 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Alphonsus Professional Medical Services Llc | 7214849751 | 58 |
| Boise Anesthesia, P A | 8426960642 | 52 |
News Archive
Nanoparticles are being developed to perform a wide range of medical uses - imaging tumors, carrying drugs, delivering pulses of heat. Rather than settling for just one of these, researchers at the University of Washington have combined two nanoparticles in one tiny package.
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
For Mike and Alice Jackson, cancer is personal; so much so that they are joining with Nova Southeastern University researchers in the fight against one of the nation's deadliest diseases. The Jacksons announced today a $1 million personal pledge to support NSU's cancer research.
For years, science has generally considered the phosphorylation of proteins - the insertion of a phosphorous group into a protein that turns it on or off - as perhaps the factor regulating a range of cellular processes from cell metabolism to programmed cell death. Now, scientists from the Florida campus of The Scripps Research Institute have identified the importance of a novel protein-regulating mechanism - called sulfenylation - that is similar to phosphorylation and may, in fact, open up opportunities to develop new types of drugs for diseases such as cancer.
Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder.
› Verified 4 days ago
| Entity Name | Boise Anesthesia, P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487602298 PECOS PAC ID: 8426960642 Enrollment ID: O20031105000132 |
News Archive
Nanoparticles are being developed to perform a wide range of medical uses - imaging tumors, carrying drugs, delivering pulses of heat. Rather than settling for just one of these, researchers at the University of Washington have combined two nanoparticles in one tiny package.
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
For Mike and Alice Jackson, cancer is personal; so much so that they are joining with Nova Southeastern University researchers in the fight against one of the nation's deadliest diseases. The Jacksons announced today a $1 million personal pledge to support NSU's cancer research.
For years, science has generally considered the phosphorylation of proteins - the insertion of a phosphorous group into a protein that turns it on or off - as perhaps the factor regulating a range of cellular processes from cell metabolism to programmed cell death. Now, scientists from the Florida campus of The Scripps Research Institute have identified the importance of a novel protein-regulating mechanism - called sulfenylation - that is similar to phosphorylation and may, in fact, open up opportunities to develop new types of drugs for diseases such as cancer.
Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder.
› Verified 4 days ago
| Entity Name | St Alphonsus Professional Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386677524 PECOS PAC ID: 7214849751 Enrollment ID: O20040205001184 |
News Archive
Nanoparticles are being developed to perform a wide range of medical uses - imaging tumors, carrying drugs, delivering pulses of heat. Rather than settling for just one of these, researchers at the University of Washington have combined two nanoparticles in one tiny package.
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
For Mike and Alice Jackson, cancer is personal; so much so that they are joining with Nova Southeastern University researchers in the fight against one of the nation's deadliest diseases. The Jacksons announced today a $1 million personal pledge to support NSU's cancer research.
For years, science has generally considered the phosphorylation of proteins - the insertion of a phosphorous group into a protein that turns it on or off - as perhaps the factor regulating a range of cellular processes from cell metabolism to programmed cell death. Now, scientists from the Florida campus of The Scripps Research Institute have identified the importance of a novel protein-regulating mechanism - called sulfenylation - that is similar to phosphorylation and may, in fact, open up opportunities to develop new types of drugs for diseases such as cancer.
Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul David Cochran, Po Box 7411114, Chicago, IL 60674-1114 Ph: (208) 367-5170 | Paul David Cochran, 1055 N Curtis Rd, Boise, ID 83706-1309 Ph: (208) 367-2559 |
News Archive
Nanoparticles are being developed to perform a wide range of medical uses - imaging tumors, carrying drugs, delivering pulses of heat. Rather than settling for just one of these, researchers at the University of Washington have combined two nanoparticles in one tiny package.
Marking World No Tobacco Day on 31st May, the Union for International Cancer Control (UICC) urges governments around the world to reduce tobacco-related cancer deaths and other diseases by increasing investment in tobacco control.
For Mike and Alice Jackson, cancer is personal; so much so that they are joining with Nova Southeastern University researchers in the fight against one of the nation's deadliest diseases. The Jacksons announced today a $1 million personal pledge to support NSU's cancer research.
For years, science has generally considered the phosphorylation of proteins - the insertion of a phosphorous group into a protein that turns it on or off - as perhaps the factor regulating a range of cellular processes from cell metabolism to programmed cell death. Now, scientists from the Florida campus of The Scripps Research Institute have identified the importance of a novel protein-regulating mechanism - called sulfenylation - that is similar to phosphorylation and may, in fact, open up opportunities to develop new types of drugs for diseases such as cancer.
Scientists from Harvard Medical School have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis, or ALS, a progressive and incurable neurodegenerative disorder.
› Verified 4 days ago
Mr. Douglas Neurath, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 | |
Jordan B Wolff, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 111 W State St, Boise, ID 83702 Phone: 208-336-0895 Fax: 208-338-1796 | |
Nathan S Call, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
Ashton Mieritz, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2121 | |
Kenneth Clark Stratton Jr., CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2559 | |
Diana San Juan Shimko, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-6416 | |
David Hansen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 338 E Bannock St, Boise, ID 83712 Phone: 208-336-0895 |